Blouse Grant E.
- SEC CIK
- 0001869883
No open-market purchases or sales filed in the past year.
Current role at each company
- GYRE Gyre Therapeutics, Inc.Chief Scientific Officeras of Aug 10, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Blouse Grant E. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2022 (view filing)5:17 PM ET | Aug 9 | 1 day | Blouse Grant E.Chief Scientific Officer | PPurchase | +3.25K | $0.47 | +$1.53K | +52.7%9.42K after | |
| Feb 16, 2022 (view filing)8:07 PM ET | Feb 9 | 7 daysLate | Blouse Grant E.Chief Scientific Officer | PPurchase | +3.25K | $0.46 | +$1.50K | +111.4%6.17K after | |
| Aug 11, 2021 (view filing) | Aug 9 | 2 days | Blouse Grant E.Chief Scientific Officer | PPurchase | +1.16K | $3.62 | +$4.21K | +66.3%2.92K after |